Sign In
Get Clay Free →

Suggestions

    Jonathan Hepple

    Founder & Director at Rosetta Capital

    Jonathan Hepple is a seasoned venture investor in life science companies with over two decades of experience in the industry.

    He is the founder of Rosetta Capital, a prominent international secondary venture firm specializing in life sciences and has made successful investments in various companies such as Carrick Therapeutics, Forward Pharma, and Zealand Pharmaceuticals.

    His portfolio boasts of notable exits including Ambit Biosciences, Cytochroma, Enobia Pharmaceuticals, and GeminX Pharmaceuticals, acquired for substantial amounts by key players in the pharmaceutical industry.

    Apart from his role at Rosetta Capital, Jonathan serves as the Senior Life Science Adviser to Oxford Science Enterprises (OSE) and holds board seats in companies like Carrick Therapeutics, Mission Therapeutics, and Nucleome Therapeutics.

    He holds a Ph.D. in Cancer Research with a focus on Protein Engineering from the University of Cambridge and has a background in Biology from the University of Oxford.

    Jonathan Hepple has an extensive track record of serving on boards and in advisory capacities for various organizations such as Seroba Kernel Life Sciences, Axelar AB, and Covagen AG, bringing his wealth of experience and expertise to guide these companies in the life science sector.

    Jonathan Hepple
    Add to my network

    Location

    London, England, United Kingdom